Detalles de la búsqueda
1.
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer.
Clin Cancer Res
; 10(15): 5048-57, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15297406
2.
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.
Clin Cancer Res
; 9(7): 2527-37, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12855627
3.
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
Clin Cancer Res
; 9(15): 5540-9, 2003 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14654534
4.
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.
Clin Cancer Res
; 18(8): 2316-25, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22261800
5.
Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.
J Clin Oncol
; 24(13): 2052-8, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16648505
6.
Have you recruited nurses without oncology experience?
ONS Connect
; 22(10): 15, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18074627
Resultados
1 -
6
de 6
1
Próxima >
>>